Prof. Kambal-Mycobacteria (Undergraduate)
... darkness and are called SCOTOCHROMOGENS, and other do not produce any pigment at all. They are called NONCHROMOGENS. Atypical mycobacteria are opportunistic and do not produce disease in the normally healthy person. ...
... darkness and are called SCOTOCHROMOGENS, and other do not produce any pigment at all. They are called NONCHROMOGENS. Atypical mycobacteria are opportunistic and do not produce disease in the normally healthy person. ...
Projects
... tissue. We propose to use molecular signatures to establish the contributory role of infections in cancer development as an alternative approach to the detection of the infectious agents itself. In this project, you will learn: 1) cancer signaling networks, 2) host-microbe interaction, 3) high-end a ...
... tissue. We propose to use molecular signatures to establish the contributory role of infections in cancer development as an alternative approach to the detection of the infectious agents itself. In this project, you will learn: 1) cancer signaling networks, 2) host-microbe interaction, 3) high-end a ...
Infection Control - Effingham County Schools
... Yeasts and molds are 2 common forms Causes diseases such as ringworm, athlete’s ...
... Yeasts and molds are 2 common forms Causes diseases such as ringworm, athlete’s ...
Infection Control in Correctional Facilities
... F. Hepatitis B Virus (HBV) 1. Attacks the liver of the victim, causing liver damage 2. The liver is necessary for a person to live 3. Victims recover 95% of the time with no permanent liver damage 4. About 5% of HBV infections become chronic 5. Symptoms may last for several months and may include: a ...
... F. Hepatitis B Virus (HBV) 1. Attacks the liver of the victim, causing liver damage 2. The liver is necessary for a person to live 3. Victims recover 95% of the time with no permanent liver damage 4. About 5% of HBV infections become chronic 5. Symptoms may last for several months and may include: a ...
Hepatitis A (PDF)
... Hepatitis A What is hepatitis A? Hepatitis A is an infection of the liver caused by the hepatitis A virus (HAV). What are the symptoms of hepatitis A? Some people have very severe symptoms and other people have no symptoms at all. Children generally have no symptoms. If symptoms occur, onset is usua ...
... Hepatitis A What is hepatitis A? Hepatitis A is an infection of the liver caused by the hepatitis A virus (HAV). What are the symptoms of hepatitis A? Some people have very severe symptoms and other people have no symptoms at all. Children generally have no symptoms. If symptoms occur, onset is usua ...
Document
... few days later, the bottom x-ray shows the cardiac silhouette has greatly enlarged because the virus has invaded the heart and damaged the heart tissue. The myocardium has been infiltrated in the interstitium by mononuclear cells as part of the host’s immune response. If you had someone with viral h ...
... few days later, the bottom x-ray shows the cardiac silhouette has greatly enlarged because the virus has invaded the heart and damaged the heart tissue. The myocardium has been infiltrated in the interstitium by mononuclear cells as part of the host’s immune response. If you had someone with viral h ...
Virus Notes - ScienceCo
... type of lymphocyte known also as a B-cell) produce special proteins called antibodies that bind to the antigens of the pathogen. o Antibodies are shaped like a ‘Y’ and contain two identical binding sites that are specific to a particular antigen. The purpose of these antibodies is to link viruses to ...
... type of lymphocyte known also as a B-cell) produce special proteins called antibodies that bind to the antigens of the pathogen. o Antibodies are shaped like a ‘Y’ and contain two identical binding sites that are specific to a particular antigen. The purpose of these antibodies is to link viruses to ...
Don`t Open the Door to Infection: Staphylococcus aureus Infections
... – Spider bite • Delayed proper treatment leads to: – Increased chance of spreading infection to others – Increased severity of infection – Increased risk of fatality ...
... – Spider bite • Delayed proper treatment leads to: – Increased chance of spreading infection to others – Increased severity of infection – Increased risk of fatality ...
Health STI/HIV PPT - Gordon State College
... for them. It is important to realize that the vaccine doesn’t protect against all cancercausing types of HPV, so Pap tests are still needed. The second way to prevent cancer of the cervix is to have a Pap test. The Pap test can detect HPV infection and pre-cancers. Treatment of these problems can st ...
... for them. It is important to realize that the vaccine doesn’t protect against all cancercausing types of HPV, so Pap tests are still needed. The second way to prevent cancer of the cervix is to have a Pap test. The Pap test can detect HPV infection and pre-cancers. Treatment of these problems can st ...
Respiratory syncytial virus
... Responsible for about 50% of common colds • > 100 serotypes of Rhinovirus • re-infection can occur • infections year-round, most prevalent in fall and spring • incubation period about 2 days • symptoms peak on the 2nd and 3rd days ...
... Responsible for about 50% of common colds • > 100 serotypes of Rhinovirus • re-infection can occur • infections year-round, most prevalent in fall and spring • incubation period about 2 days • symptoms peak on the 2nd and 3rd days ...
Slide Presentation - Powerpoint
... When present, they can include: •Nausea, vomiting, fever, abdominal or joint pain •Loss of appetite •Fatigue •Yellowing of the skin or eyes •Dark Urine •Clay-colored bowel movements Source: Centers for Disease Control and Prevention ...
... When present, they can include: •Nausea, vomiting, fever, abdominal or joint pain •Loss of appetite •Fatigue •Yellowing of the skin or eyes •Dark Urine •Clay-colored bowel movements Source: Centers for Disease Control and Prevention ...
Lecture 31 Emerging viruses - University of Maryland
... breath), headache, and hypoxaemia (low blood oxygen concentration). • Typical laboratory findings include lymphopaenia (reduced lymphocyte numbers) and mildly elevated aminotransferase levels (indicating liver damage). • Death may result from progressive respiratory failure due to alveolar damage. • ...
... breath), headache, and hypoxaemia (low blood oxygen concentration). • Typical laboratory findings include lymphopaenia (reduced lymphocyte numbers) and mildly elevated aminotransferase levels (indicating liver damage). • Death may result from progressive respiratory failure due to alveolar damage. • ...
Slide Presentation - Powerpoint
... When present, they can include: •Nausea, vomiting, fever, abdominal or joint pain •Loss of appetite •Fatigue •Yellowing of the skin or eyes •Dark Urine •Clay-colored bowel movements Source: Centers for Disease Control and Prevention ...
... When present, they can include: •Nausea, vomiting, fever, abdominal or joint pain •Loss of appetite •Fatigue •Yellowing of the skin or eyes •Dark Urine •Clay-colored bowel movements Source: Centers for Disease Control and Prevention ...
Chain of infection
... o Specific immune response. i.e protective antibodies that are directed against a specific agent. ...
... o Specific immune response. i.e protective antibodies that are directed against a specific agent. ...
Word 753KB - Fiona Stanley Hospital
... Patients must be tested for HCV RNA at least 12 weeks after completing treatment to determine outcome. Please notify the specialist below of the Week 12 post-treatment result. Declaration by General Practitioner I declare all of the information provided above is true and correct. ...
... Patients must be tested for HCV RNA at least 12 weeks after completing treatment to determine outcome. Please notify the specialist below of the Week 12 post-treatment result. Declaration by General Practitioner I declare all of the information provided above is true and correct. ...
Peste des Petits Ruminants
... Transmission • Close contact, inhalation • Virus shed in nasal and ocular secretions, saliva, urine, and feces • Long-term carriers unlikely • Role of fomites unclear – Do not remain infectious for long ...
... Transmission • Close contact, inhalation • Virus shed in nasal and ocular secretions, saliva, urine, and feces • Long-term carriers unlikely • Role of fomites unclear – Do not remain infectious for long ...
Retroviruses
... they independently discovered RT activity in infected cells 1980: Human T-cell leukemia virus discovered, the first pathogenic human retrovirus. 1982: Human immunodeficiency virus discovered. 1990: First gene therapy trial involving the use of retroviral-based vectors in patient with a deficiency in ...
... they independently discovered RT activity in infected cells 1980: Human T-cell leukemia virus discovered, the first pathogenic human retrovirus. 1982: Human immunodeficiency virus discovered. 1990: First gene therapy trial involving the use of retroviral-based vectors in patient with a deficiency in ...
Viruses - Arkansas State University
... • Organ/tissue/cell culture – Minced tissue, separated into cells by enzyme treatment – Grown in sterile plastic dish with nutrient solution – Cells prepared this way grow until dish is covered, stop. • Scrape up, use some to inoculate new culture • Limited number of rounds of replication – Transfor ...
... • Organ/tissue/cell culture – Minced tissue, separated into cells by enzyme treatment – Grown in sterile plastic dish with nutrient solution – Cells prepared this way grow until dish is covered, stop. • Scrape up, use some to inoculate new culture • Limited number of rounds of replication – Transfor ...
There Is No Evidence That the Free-Living Ameba Hartmannella Is a
... morphologically, it reacted with antiserum produced in response to Acanthamoeba [9] but not with antisera produced in response to Naegleria, Hartmannella, and Vahlkampfia. Thus, morphological identification also might not be reliable. Before B. mandrillaris was described as a new genus and species, ...
... morphologically, it reacted with antiserum produced in response to Acanthamoeba [9] but not with antisera produced in response to Naegleria, Hartmannella, and Vahlkampfia. Thus, morphological identification also might not be reliable. Before B. mandrillaris was described as a new genus and species, ...
Page 1 of 6 EBBA-R - PREVENTION OF DISEASE/INFECTION
... and other body fluids from individuals with a known disease or infection and from those individuals who are asymptomatic undiagnosed individuals, and/or known to be free of pathogens. Blood is the single most important source of infection. Other body fluids that may cause disease include, but are no ...
... and other body fluids from individuals with a known disease or infection and from those individuals who are asymptomatic undiagnosed individuals, and/or known to be free of pathogens. Blood is the single most important source of infection. Other body fluids that may cause disease include, but are no ...
African and Asian Zika virus strains differentially induce early
... but also chemokines and gene products involved in the activation of the inflammasome pathway (Fig. 2). Notably, the kinetics of induction of the antiviral responses by astrocytes differed significantly between the two ZIKV strains (Fig. 2A, B and C), whereas infection of astrocytes with the Asian stra ...
... but also chemokines and gene products involved in the activation of the inflammasome pathway (Fig. 2). Notably, the kinetics of induction of the antiviral responses by astrocytes differed significantly between the two ZIKV strains (Fig. 2A, B and C), whereas infection of astrocytes with the Asian stra ...
sti counselling
... Both in Canada and around the world, STIs are on the rise. As many individuals don’t realize that STIs can be asymptomatic, education and awareness are key to prevention and treatment of STIs. Furthermore, early intervention after potential infection, partner notification, and abstinence until compl ...
... Both in Canada and around the world, STIs are on the rise. As many individuals don’t realize that STIs can be asymptomatic, education and awareness are key to prevention and treatment of STIs. Furthermore, early intervention after potential infection, partner notification, and abstinence until compl ...
Hepatitis B
Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) which affects the liver. It can cause both acute and chronic infections. Many people have no symptoms during the initial infection. Some develop a rapid onset of sickness with vomiting, yellowish skin, feeling tired, dark urine and abdominal pain. Often these symptoms last a few weeks and rarely does the initial infection result in death. It may take 30 to 180 days for symptoms to begin. In those who get infected around the time of birth 90% develop chronic hepatitis B while less than 10% of those infected after the age of five do. Most of those with chronic disease have no symptoms; however, cirrhosis and liver cancer may eventually develop. These complications results in the death of 15 to 25% of those with chronic disease.The virus is transmitted by exposure to infectious blood or body fluids. Infection around the time of birth or from contact with other people's blood during childhood is the most frequent method by which hepatitis B is acquired in areas where the disease is common. In areas where the disease is rare, intravenous drug use and sexual intercourse are the most frequent routes of infection. Other risk factors include working in healthcare, blood transfusions, dialysis, living with an infected person, travel in countries where the infection rate is high, and living in an institution. Tattooing and acupuncture led to a significant number of cases in the 1980s; however, this has become less common with improved sterility. The hepatitis B viruses cannot be spread by holding hands, sharing eating utensils, kissing, hugging, coughing, sneezing, or breastfeeding. The infection can be diagnosed 30 to 60 days after exposure. Diagnosis is typically by testing the blood for parts of the virus and for antibodies against the virus. It is one of five known hepatitis viruses: A, B, C, D, and E.The infection has been preventable by vaccination since 1982. Vaccination is recommended by the World Health Organization in the first day of life if possible. Two or three more doses are required at a later time for full effect. This vaccine works about 95% of the time. About 180 countries gave the vaccine as part of national programs as of 2006. It is also recommended that all blood be tested for hepatitis B before transfusion and condoms be used to prevent infection. During an initial infection, care is based on the symptoms that a person has. In those who develop chronic disease antiviral medication such as tenofovir or interferon maybe useful, however these drugs are expensive. Liver transplantation is sometimes used for cirrhosis.About a third of the world population has been infected at one point in their lives, including 240 million to 350 million who have chronic infections. Over 750,000 people die of hepatitis B each year. About 300,000 of these are due to liver cancer. The disease is now only common in East Asia and sub-Saharan Africa where between 5 and 10% of adults have chronic disease. Rates in Europe and North America are less than 1%. It was originally known as serum hepatitis. Research is looking to create foods that contain HBV vaccine. The disease may affect other great apes as well.